Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Inventory (2023 - 2024)

Mangoceuticals' Inventory history spans 2 years, with the latest figure at -$18501.0 for Q4 2024.

  • On a quarterly basis, Inventory fell 200.0% to -$18501.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$18501.0, a 200.0% decrease, with the full-year FY2024 number at -$18501.0, down 200.0% from a year prior.
  • Inventory hit -$18501.0 in Q4 2024 for Mangoceuticals, down from $13213.0 in the prior quarter.
  • Over the last five years, Inventory for MGRX hit a ceiling of $23494.0 in Q2 2023 and a floor of -$18501.0 in Q4 2024.